The goal of this program is to improve management of acute ischemic stroke using tissue plasminogen activators. After hearing and assimilating this program, the clinician will be better able to:
1. Compare the characteristics, pharmacokinetics, clinical efficacy, and safety of tenecteplase and alteplase for the management of stroke.
2. Identify situations in which tenecteplase may be beneficial in the management of stroke.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Neurology
- Start Date: 2022-03-12 06:00:00
- End Date: 2022-03-12 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest